Log in or Sign up for Free to view tailored content for your specialty!
Hospital Medicine News
Study provides ‘greater insight’ into MIS-C
Two peaks of multisystem inflammatory syndrome in children — the rare but severe condition associated with SARS-CoV-2 infection — occurred 2 to 5 weeks after peaks of COVID-19 in United States, experts reported in JAMA Pediatrics.
Contact precautions reduce MRSA transmission by almost 50% in VA hospitals
Researchers estimated that contact precautions were associated with a nearly 50% reduction in the MRSA transmission rate among adult patients in more than 100 Veterans Affairs hospitals, according to a study published in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
‘Landmark discovery’: C. auris isolated from environment for first time
Researchers isolated Candida auris from a salt marsh and sandy beach in the Andaman Islands, suggesting that before its recognition as a human pathogen, it existed as an environmental fungus, they said.
FDA says HCP can transition away from reusing disposable respirators
The FDA recommended that facilities begin to move away from “crisis capacity conservation measures” implemented during the COVID-19 pandemic, such as reusing decontaminated respirators.
Hospital-initiated interventions promote patient-centered care for people with SUDs
Patients with substance use disorders who received navigation services in the hospital through 3 months after discharge had lower rates of ED readmission vs. those who received usual care, according to recent data from a single-center trial.
RCT shows tedizolid may be effective alternative to linezolid for gram-positive HABP, VABP
In a randomized controlled trial, tedizolid was noninferior to linezolid for day 28 all-cause mortality in the treatment of gram-positive ventilated hospital-acquired bacterial pneumonia and ventilator-associated pneumonia.
Italian hospitals struggle with surge of COVID-19 as vaccination campaign gains speed
ASOLO, Italy — Italy, at the forefront of the COVID-19 pandemic a year ago, is still struggling, with hospitals under pressure despite encouraging signs of a decrease in the number of reported cases.
Pfizer and BioNTech say COVID-19 vaccine protects adolescents, plan to submit data to FDA
Pfizer and BioNTech said Wednesday that their COVID-19 vaccine was highly protective among children aged 12 to 15 years in a phase 3 trial.
Remdesivir shortens time to improvement, but has no significant mortality effect
Patients hospitalized with COVID-19 had shorter times to clinical improvement when treated with remdesivir, but the drug had no significant effect in a time-to-death analysis, even when given with corticosteroids, according to researchers.
Initial WHO report finds no conclusive evidence of SARS-CoV-2 origin
A team of investigators who traveled to China did not find conclusive evidence of the origin of SARS-CoV-2, although they said humans were “likely to very likely” exposed through an intermediary animal host.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read